Anyone can develop an inflammation but in some people it may be silent Therefore getting proper tests can help confirm your condition and assist you with the best possible treatment ...

The pilot will use the fast-acting drug Fibrinogen, which has shown promising results in a Welsh study for its clinical benefits ...

Grifols is gearing up to file for approval of a drug for rare bleeding disorder acquired fibrinogen deficiency (AFD) that could provide a more reliable and easier treatment for patients.

The study "emphasizes the need for methods to reduce ... exposure in humans." Researchers sound alarm over concerning link to increased risk of blood clots — here's what they found first appeared on ...

Spanish firm Grifols (MCE: GRF) has submitted a Biologics License Application (BLA) for its new potential fibrinogen treatment to the US Food and Drug Administration (FDA). Grifols claims that its ...

fncls.ssp?fn=show_t_gif&application_id=2063989&application_name=news&site_id=newmediawire~~~ce31e09e-58c0-4982-8e07-f69a10de079e ...

C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), fibrinogen, and serum amyloid A. High sugar consumption can contribute to inflammation in several ways, such as promoting insulin ...

Introduction During the first wave of the COVID-19 outbreak in China, the surge of COVID-19 cases was rapid and drastic. Emerging evidence suggests that beyond the acute phase, patients with COVID-19 ...

A MATERNITY unit has received additional funding to launch a two-year pilot to help revolutionise care for birthing mothers, ...

Sturtevant, J. M., Laskowski, jun., M., Donnelly, T. H., and Scheraga, H. A., J. Amer. Chem. Soc., 77, 6168 (1955).